VC23

Codetta Bio is a life sciences company focused on developing a novel multi-omic analysis platform that utilizes digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR). This integrated platform combines reagents, hardware, and software to facilitate multiplexed, multi-omic analyses of liquid biopsies, as well as isolated DNA, RNA, and protein samples. By providing a quantitative and spatially resolved solution, Codetta Bio aims to enhance the understanding of genetic, environmental, lifestyle, and clinical factors that influence individual health. The platform is designed to streamline workflows for researchers, enabling efficient analysis of various targets, including viral and bacterial pathogens, genetic mutations, and protein expressions. Ultimately, the company's innovative technology seeks to accelerate the research and development of next-generation therapies, thereby improving patient care and overall quality of life.

Fluent BioSciences is a life science technology company focused on single-cell molecular analysis, eliminating the need for complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), facilitates the instantaneous self-assembly of individual cells or molecules into millions of uniform partitions. This innovative approach allows for sensitive and unbiased preparation of proteins and nucleic acids, enhancing sequencing applications. By making single-cell and molecular analysis more accessible, Fluent BioSciences enables a broader range of researchers in biotechnology, pharmaceuticals, and academic institutions to conduct advanced analyses, thereby expanding market opportunities within the life sciences field.

Tangen Biosciences is a biotechnology company that offers molecular diagnostic technology services. It develops medical instruments that provide rapid nucleic acid detection with the specificity and sensitivity of polymerase chain reaction (PCR) amplification.